Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Polyp Biopsy Market Value Growth And Long-Term Outlook
The polyp biopsy market size has experienced significant growth in recent years. It is anticipated to expand from $1.39 billion in 2025 to $1.5 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.5%. This market’s historical growth can be attributed to factors such as the increasing occurrence of gastrointestinal and cervical cancers, advancements in endoscopic technologies, the expansion of screening programs, heightened awareness regarding the benefits of early diagnosis, and the establishment of more specialty clinics.
The polyp biopsy market size is anticipated to demonstrate significant expansion in the coming years. It is projected to achieve a value of $2.06 billion in 2030, progressing at a compound annual growth rate (CAGR) of 8.2%. The increase expected during this forecast period can be attributed to several factors, including AI-assisted biopsy procedures, the utilization of minimally invasive techniques, a broader adoption by hospitals and diagnostic laboratories, integration with imaging and cloud platforms, and the creation of innovative biopsy tools. Prominent trends observed in the forecast timeframe include colonoscopy biopsy, colposcopy-directed biopsy, esophagogastroduodenoscopy biopsy, laryngoscopy biopsy, and endoscopic mucosal resection (emr).
Get A Free Sample Report With In-Depth Market Insights:
Polyp Biopsy Market Growth Momentum: What Factors Are Shaping Demand?
The growing occurrence of colorectal cancer is anticipated to drive expansion in the polyp biopsy market in the coming years. This malignant condition, colorectal cancer, develops in the colon or rectum due to the unregulated proliferation of epithelial cells within the large intestine, known for its capacity to infiltrate adjacent tissues and spread to other parts of the body. A key factor contributing to this rise in colorectal cancer cases is prevalent dietary habits rich in processed items and lacking fiber, which can lead to persistent inflammation, changes in gut bacteria, and foster the formation of precancerous growths capable of evolving into cancer. Polyp biopsy plays a crucial role in lessening the effects of the increasing incidence of colorectal cancer by allowing for the early identification and microscopic assessment of abnormal lesions, thus facilitating prompt treatment and hindering the disease’s advancement. As an illustration, the American Cancer Society (ACS), a US-based non-profit, forecasts that in 2025, approximately 107,320 new cases of colon cancer and 46,950 cases of rectal cancer will be diagnosed in the United States, with an estimated 52,900 deaths attributed to these cancers. Consequently, the escalating incidence of colorectal cancer is fueling the expansion of the polyp biopsy market.
Polyp Biopsy Market Segmentation And Category Overview
The polyp biopsy market covered in this report is segmented –
1) By Type: Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy
2) By Technique: Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), Conventional Biopsy
3) By Application: Colorectal Cancer, Gastrointestinal Disorders, Other Applications
4) By End-User: Hospitals, Specialty Clinics
Subsegments:
1) By Colonoscopy: Diagnostic Colonoscopy, Therapeutic Colonoscopy
2) By Colposcopy-Directed Biopsy: Cervical Biopsy, Vaginal Biopsy, Vulvar Biopsy
3) By Esophagogastroduodenoscopy: Diagnostic Esophagogastroduodenoscopy, Therapeutic Esophagogastroduodenoscopy
Polyp Biopsy Market Trends Redefining Industry Growth
Leading companies in the polyp biopsy market are concentrating on developing innovative advancements, such as AI-assisted detection systems, to improve the identification of colorectal polyps and facilitate the early recognition of potential cancerous lesions. An AI-assisted detection system is a technology designed to analyze medical imaging in real-time, pinpointing potential abnormalities and issuing visual alerts to clinicians, thereby supporting clinical decision-making without requiring therapeutic interventions. For example, in September 2024, Odin Medical Ltd., a US-based medical technology company associated with Olympus Corporation, introduced CADDIE, a cloud-based AI endoscopic system. The CADDIE device uses cloud-based artificial intelligence to analyze colonoscopy video live and emphasize areas with suspected colorectal polyps, enabling endoscopists to make informed choices during procedures. Clinical trials have indicated that the system enhances the adenoma detection rate without increasing procedural time or risk, emphasizing its potential to improve early detection and patient care.
Polyp Biopsy Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the polyp biopsy market are Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical
View The Full Polyp Biopsy Market Report:
Polyp Biopsy Market Geographic Distribution And Regional Opportunities
North America was the largest region in the polyp biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polyp biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model





